BOLT vs CFLT · rev $7.7M vs rev $963.6M
Bolt Biotherapeutics (BOLT) versus Confluent Inc (CFLT) — a side-by-side from cached financials, not a winner call.
Bolt Biotherapeutics (BOLT) is a biotechnology company listed on US.
Confluent Inc (CFLT) is a software - infrastructure company listed on US.
Latest reported BOLT revenue for 2024-12-31 was $7.7M. Net income was -$63.1M. Revenue was down 2.4% from 2023-12-31 to 2024-12-31. BOLT currently screens at market cap $11.3M.
Latest reported CFLT revenue for 2024-12-31 was $963.6M. Net income was -$345.1M. Revenue was up 24.0% from 2023-12-31 to 2024-12-31. CFLT currently screens at market cap $11.13B.
BOLT currently screens at market cap $11.3M. CFLT currently screens at market cap $11.13B.
Not investment advice. Open the BOLT and CFLT stock pages for the full models.
Not investment advice.